14 min
High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS JAMA Neurology Author Interviews
-
- Medicina
Interview with Anne Kerbrat, MD, PhD, author of High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS. Hosted by Cynthia E. Armand, MD.
Related Content:
High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS
Interview with Anne Kerbrat, MD, PhD, author of High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS. Hosted by Cynthia E. Armand, MD.
Related Content:
High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS
14 min
Más de JAMA Network
JAMAevidence JAMA Guide to Statistics and Methods
JAMA Network
Coronavirus (COVID-19) Q&A
JAMA Network
JAMA Network Open Conversations
JAMA Network
JAMAevidence Users' Guides to the Medical Literature
JAMA Network
JAMAevidence The Rational Clinical Examination
JAMA Network
JAMAevidence Care at the Close of Life
JAMA Network